ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
ERYTECH Confirms Plans To Submit BLA for Eryaspase in Hypersensitive ALL Patients
July 22, 2021ERYTECH today announced its intention to move forward towards the submission of a BLA to the US Food and Drug Administration for eryaspase in hypersensitive acute lymphoblastic leukemia patients following feedback from the agency in a pre-BLA meeting. -
Erytech and Queen’s University collaborate for arginase-1 deficiency treatment
July 14, 2017French biopharmaceutical company Erytech Pharma has entered a research collaboration with Queen’s University in Canada to advance the preclinical development of its eryminase programme, particularly for the treatment of arginase-1 deficiency.
Pharma Sources Insight January 2025
